Patents by Inventor Cindy A. Wilson

Cindy A. Wilson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Orphan Receptor Tyrosine Kinase as a Target in Breast Cancer
    Publication number: 20080318212
    Abstract: Methods and materials relating to the orphan receptor tyrosine kinase (ROR1) are described. ROR1 exhibits restricted tissue expression in normal adult tissue and is overexpressed in certain breast cancer subtypes. ROR1 provides a diagnostic and/or therapeutic target for breast cancers.
    Type: Application
    Filed: April 6, 2005
    Publication date: December 25, 2008
    Inventors: Cindy A. Wilson, Judy Dering, Dennis J. Slamon
  • Apparatus and system for teaching proper letter sizing and spacing to autistic children and others with deficiencies in the areas of visual processing, motor control and/or sensory processing
    Patent number: 7407383
    Abstract: The present disclosure relates to the area of assistive technology, and specifically discloses an apparatus and method for teaching proper letter sizing and spacing to autistic children and others having deficiencies in the areas of visual processing, motor control and sensory processing, through the use of a novel writing guide and graduated method for using same.
    Type: Grant
    Filed: September 22, 2005
    Date of Patent: August 5, 2008
    Assignee: Green Bean Products, Inc.
    Inventor: Cindy Wilson Bean
  • Constraints-based analysis of gene expression data
    Publication number: 20050079508
    Abstract: In accordance with one aspect of the invention, a constraints-based method of analysis of gene expression data has been shown to provide a useful method for target identification in gene expression profiles. Such constraints-based methods of analysis provide useful analytical methods that focus on genes and related pathways that are likely to be important in disease progression, that is, to provide likely candidates that will serve as targets for various therapeutics.
    Type: Application
    Filed: October 10, 2003
    Publication date: April 14, 2005
    Inventors: Judy Dering, Cindy Wilson, Dennis Slamon
  • HER-2/neu overexpression abrogates growth inhibitory pathways
    Patent number: 6767541
    Abstract: The present invention provides methods for obtaining genetic profiles of cancer cells in order to assess the status of a cancer in an individual. In addition, the present invention provides methods for inhibiting the growth of cancer cells that exhibit certain genetic profiles. These methods identify an important link between HER-2/neu overexpression and loss of growth inhibition by the TGF-&bgr; signaling pathway in cancer cells. Compositions as well as therapeutic and diagnostic methodologies based on this disclosure are provided.
    Type: Grant
    Filed: March 20, 2001
    Date of Patent: July 27, 2004
    Assignees: The Regents of the University of California, Amgen Inc.
    Inventors: Dennis J. Slamon, Cindy A. Wilson, Frank J. Calzone
  • HER -2/neu overexpression abrogates growth inhibitory pathways
    Publication number: 20020051785
    Abstract: The present invention provides methods for obtaining genetic profiles of cancer cells in order to assess the status of a cancer in an individual. In addition, the present invention provides methods for inhibiting the growth of cancer cells that exhibit certain genetic profiles. These methods identify an important link between HER-2/neu overexpression and loss of growth inhibition by the TGF-&bgr; signaling pathway in cancer cells. Compositions as well as therapeutic and diagnostic methodologies based on this disclosure are provided.
    Type: Application
    Filed: March 20, 2001
    Publication date: May 2, 2002
    Applicant: The Regents of the University of California and Amgen Inc.
    Inventors: Dennis J. Slamon, Cindy A. Wilson, Frank J. Calzone